Quantitative clinical pharmacology consultancy which supports drug developers with modelling based decision making, drawing on decades of combined experience across biologics, small molecules and new therapeutic types. Provides population pharmacokinetic and pharmacokinetic and pharmacodynamic analysis, exposure response analysis, model based meta-analysis, dose and regimen selection, support for regulatory filings and clinical pharmacology strategy from translational work through to post-marketing, together with mentoring and training in these methods.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen